# Editas Medicine, Inc.: Form 8-K, filed Jan 9, 2023

- Company: [Editas Medicine, Inc.](/companies/edit.md) (CIK 1650664)
- Form: 8-K
- Filed: 2023-01-09
- Accepted by EDGAR: Jan 9, 2023, 08:36 ET
- Period: 2023-01-07
- Accession: 0001558370-23-000130
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1650664/000155837023000130/edit-20230107x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1650664/000155837023000130/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1650664/000155837023000130/edit-20230107x8k.htm

Filed Jan 9, 2023.
Source: SEC EDGAR, the filing index for accession 0001558370-23-000130. Last ingested by Listed: Nov 10, 2026, 02:10 ET. No prices; not investment advice.